Canadian company moves ahead with regenerative skin technology

11/15/2013 | Metro (Canada)

Canada-based DeCell Technologies announced plans to use an equity investment of approximately $239,000 to finish development and human testing of a product based on donated human skin that can treat diabetic foot ulcers, chronic wounds, burns and surgical wounds. When applied to wounds, the biological dressing promotes tissue regeneration.

View Full Article in:

Metro (Canada)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
Winston-Salem, NC
Director of Product Planning Development; Market Planning, Innovation
Blue Cross Blue Shield of Massachusetts
Quincy , MA
Director, Payer Marketing
Avalere Health
Washington, DC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX